Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet
Phase 3
Recruiting
- Conditions
- Crow's Feet
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Humedix Co., Ltd.
- Target Recruit Count
- 171
- Registration Number
- NCT06428253
- Locations
- 🇰🇷
Chung-Ang University Hospital, Seoul, Heukseok-ro, Dongjak-gu, Korea, Republic of
News
No news found